United Therapeutics director sells 1,210 shares

The reported position after the exercise included 3,000 stock options, alongside 1,100 common shares held indirectly by a trust.

Available on EDGAR 11/10/2026 - 04:34 PM EST Accepted by SEC EDGAR 11/10/2026 - 04:34 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

United Therapeutics Corp. (UTHR) director Christopher Patusky exercised stock options covering 1,210 common shares at an exercise price of $132.30 per share on November 9, 2026, then sold 1,210 common shares at $580 per share that day. The reported position after the exercise included 3,000 stock options; 1,100 common shares were held indirectly by a trust. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and Sale: 1,210 shares ($542K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider PATUSKY CHRISTOPHER

Role Director

Sold 1,210 shs ($702K)

Approx. gross sale proceeds $702K

Approx. exercise cost $160K

Approx. pre-tax spread $542K

Type	Security	Shares	Price	Value
Exercise	Stock Option	1,210	$0.00	$0.00
Exercise	Common Stock F1	1,210	$132.30	$160K
Sale	Common Stock	1,210	$580.00	$702K
Holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option — 3,000 options (Direct); Common Stock — 2,140 shares (Direct); Common Stock — 1,100 shares (Indirect, by Trust)

Footnotes (1)

1. F1. The Form 4 filed by the Reporting Person on July 23, 2026 incorrectly reported the Amount of Securities Beneficially Owned following Reported Transaction in Column 5 of Table I. The correct number should have been 2,140.

Key Figures

Stock options exercised: 1,210 options Exercise price: $132.30 per share Common shares sold: 1,210 shares +3 more

6 metrics

Stock options exercised 1,210 options November 9, 2026

Exercise price $132.30 per share November 9, 2026

Common shares sold 1,210 shares November 9, 2026

Sale price $580 per share November 9, 2026

Stock options following exercise 3,000 options Reported position after the November 9, 2026 exercise

Common shares held indirectly by a trust 1,100 shares Reported November 9, 2026

Key Terms

Stock Option, Exercise price, Beneficially Owned

3 terms

Stock Option financial

"Stock Option"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Exercise price financial

"exercise price of $132.30 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Beneficially Owned financial

"Amount of Securities Beneficially Owned following Reported Transaction"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did UTHR director Christopher Patusky report on November 9, 2026?

Christopher Patusky exercised stock options covering 1,210 common shares at an exercise price of $132.30 per share and sold 1,210 common shares at $580 per share on November 9, 2026. No Rule 10b5-1 plan is reported.

How many stock options did Christopher Patusky hold after the UTHR exercise?

The reported position after the exercise was 3,000 stock options.

What figure did the footnote correct in UTHR's earlier Form 4?

The footnote says the Form 4 filed July 23, 2026 incorrectly reported the amount of securities beneficially owned following the reported transaction in Column 5 of Table I; the correct number was 2,140.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PATUSKY CHRISTOPHER

(Last) (First) (Middle)

C/O UNITED THERAPEUTICS CORPORATION

1000 SPRING STREET

(Street)

SILVER SPRING MARYLAND 20910

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/09/2026		M		1,210	A	$132.3	3,350(1)	D
Common Stock	11/09/2026		S		1,210	D	$580	2,140	D
Common Stock								1,100	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$132.3	11/09/2026		M			1,210	06/28/2018	06/28/2027	Common Stock	1,210	$0.00	3,000	D

Explanation of Responses:

1. The Form 4 filed by the Reporting Person on July 23, 2026 incorrectly reported the Amount of Securities Beneficially Owned following Reported Transaction in Column 5 of Table I. The correct number should have been 2,140.

Remarks:

	/s/ John S. Hess, Jr. under Power of Attorney	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)